That opens the door for broader access to Zepbound, which is not currently covered by Medicare and many other insurance plans for weight loss. Demand for the injection has soared over the last year ...
Important Milestone Clears the Way for Millions of Medicare Beneficiaries with Sleep Apnea to Access Vivos’ Patented and FDA-Cleared Oral Appliance Treatment LITTLETON, Colo., July 01, 2025 (GLOBE ...
Money Talks News on MSN
Pill Could Revolutionize Sleep Apnea Care, Say Experts
A new pill for sleep apnea could offer hope for those struggling with CPAP machines, according to leading researchers.
Medicare Part D plans may cover Zepbound if it is prescribed for obstructive sleep apnea (OSA), as this drug has FDA approval for this condition in individuals living with obesity. Medicare typically ...
Vivos Therapeutics shares were 24% higher, at $3.91, after the company said its VidaSleep oral appliance was approved by the Centers for Medicare & Medicaid Services Pricing, Data Analysis and Coding ...
LITTLETON, Colo., July 01, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (VVOS) (“Vivos” or the “Company”), a pioneering medical technology company revolutionizing the treatment of obstructive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback